Abstract
Venlafaxine represents a new class of antidepressant, the serotonin and noradrenaline re-uptake inhibitor (or SNRI). This article discusses its evolution, pharmacological properties and role in the treatment of depression and related disorders, beginning with an outline of the biology of depression.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antidepressive Agents, Second-Generation / administration & dosage*
-
Antidepressive Agents, Second-Generation / pharmacokinetics
-
Anxiety Disorders / drug therapy
-
Cyclohexanols / administration & dosage*
-
Cyclohexanols / pharmacokinetics
-
Depressive Disorder / diagnosis
-
Depressive Disorder / drug therapy*
-
Humans
-
Venlafaxine Hydrochloride
Substances
-
Antidepressive Agents, Second-Generation
-
Cyclohexanols
-
Venlafaxine Hydrochloride